Next-Generation Biomanufacturing Market Size is valued at 24.9 Billion in 2024 and is predicted to reach 80.0 Billion by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Biomanufacturing is the production process of biomolecules by utilizing biological services to use in medical & industrial applications. Next-generation biomanufacturing products provide superior services in terms of quality and efficiency compared to first-generation biomanufacturing products.
Major driving factors of the next-generation biomanufacturing market are rising government funding for the development of modern bioprocessing technologies, rapid adoption of advanced technologies, increasing investments by pharma companies to develop & adopt next-generation biomanufacturing products, growing patient population, and increasing awareness among the people regarding the benefits of next-generation biomanufacturing. With the growing demand for drugs and therapies, many biopharmaceutical companies prefer adopting next-generation biomanufacturing services to balance the process design, performance, & efficiency with time and cost. This development is estimated to propel the market growth opportunities over the forecast years. However, complex manufacturing and development procedures and a lack of specialized expertise may hinder the market growth during the estimated timeframe.
The next-generation biomanufacturing market is segmented into medical applications, products, workflow, end-users, and regions. The medical applications segment comprises monoclonal antibodies, hormones, vaccines, recombinant proteins, and other applications. Due to their increasing medical applications, the monoclonal antibodies segment will dominate this market during the forecast years. Based on the products, the market is divided into continuous upstream biomanufacturing products, single-use upstream biomanufacturing products, and downstream biomanufacturing products. The market is classified into upstream and downstream biomanufacturing based on workflow. By end-users, the market is segmented into biopharmaceutical companies, CMOs (contract manufacturing organizations)/CDMOs (contract development and manufacturing organization), and research institutions. Biopharmaceutical companies are estimated to hold a significant market share in the coming years owing to the growing prevalence of chronic diseases and the high demand for protein/drug production. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
North America led the market due to the robust presence of large biopharmaceutical businesses, the improved infrastructure in biological research, and the rising usage of innovative technologies. The Asia-Pacific market is expected to witness the fastest growth during the forecast period due to the rapid adoption of advanced technologies, rising patient pool, and the high prevalence of chronic diseases. Apart from this, Europe holds the second position in this market regarding revenue share.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 24.9 Billion |
|
Revenue forecast in 2034 |
USD 80.0 Billion |
|
Growth rate CAGR |
CAGR of 12.6% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
By Medical Applications, Products, Workflow, End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia |
|
Competitive Landscape |
Applikon Biotechnology BV (Netherlands), bbi-biotech GmbH (Germany), Danaher Corporation (US), Eppendorf AG (Germany), Esco Group of Companies (US), GEA Group Aktiengesellschaft (Germany), Meissner Filtration Products, Inc. (US), Merck KGaA (Germany), PBS Biotech, Inc. (US), Pierre Guérin (France), Sartorius AG (Germany), Shanghai Bailun Biotechnology Co. Ltd. (China), Solaris Biotechnology Srl. (Italy), Thermo Fisher Scientific Inc. (US), ZETA GmbH (Austria), and other. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next-Generation Biomanufacturing Market Snapshot
Chapter 4. Global Next-Generation Biomanufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Medical Applications, Estimates & Trend Analysis
5.1. By Medical Applications, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Medical Applications:
5.2.1. Monoclonal Antibodies
5.2.2. Hormones
5.2.3. Vaccines
5.2.4. Recombinant Proteins
5.2.5. Other Applications
Chapter 6. Market Segmentation 2: By Products Estimates & Trend Analysis
6.1. By Products & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
6.2.1. Continuous Upstream Biomanufacturing Products
6.2.2. Single-Use Upstream Biomanufacturing Products
6.2.3. Downstream Biomanufacturing Products
Chapter 7. Market Segmentation 3: By Workflow Estimates & Trend Analysis
7.1. By Workflow & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Workflow:
7.2.1. Upstream Biomanufacturing
7.2.2. Downstream Biomanufacturing
Chapter 8. Market Segmentation 4: By End-Users Estimates & Trend Analysis
8.1. By End-Users & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users
8.2.1. Biopharmaceutical Companies
8.2.2. CMOs/CDMOs
8.2.3. Research Institutions
Chapter 9. Next-Generation Biomanufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Medical Applications, 2021-2034
9.1.2. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.1.3. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Workflow, 2021-2034
9.1.4. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.1.5. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, 2021-2034
9.2.2. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, 2021-2034
9.2.3. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, 2021-2034
9.2.4. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.2.5. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, 2021-2034
9.3.2. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, 2021-2034
9.3.3. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, 2021-2034
9.3.4. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.3.5. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, (US$ Million) 2021-2034
9.4.2. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, (US$ Million) 2021-2034
9.4.3. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, (US$ Million) 2021-2034
9.4.4. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.4.5. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.5.5. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Applikon Biotechnology BV
10.2.2. bbi-biotech GmbH
10.2.3. Danaher Corporation
10.2.4. Eppendorf AG
10.2.5. Esco Group of Companies
10.2.6. GEA Group Aktiengesellschaft
10.2.7. Meissner Filtration Products, Inc.
10.2.8. Merck KGaA
10.2.9. PBS Biotech, Inc.
10.2.10. Pierre Guérin
10.2.11. Sartorius AG
10.2.12. Shanghai Bailun Biotechnology Co. Ltd.
10.2.13. Solaris Biotechnology Srl.
10.2.14. Thermo Fisher Scientific Inc.
10.2.15. ZETA GmbH
10.2.16. Other Prominent Players
Global Next-Generation Biomanufacturing Market, by Medical Applications,
Global Next-Generation Biomanufacturing Market, by Products,
Global Next-Generation Biomanufacturing Market, by Workflow,
Global Next-Generation Biomanufacturing Market, by End-Users,
Global Next-Generation Biomanufacturing Market, by Region,
North America Next-Generation Biomanufacturing Market, by Country,
Europe Next-Generation Biomanufacturing Market, by Country,
Asia Pacific Next-Generation Biomanufacturing Market, by Country,
Latin America Next-Generation Biomanufacturing Market, by Country,
Middle East & Africa Next-Generation Biomanufacturing Market, by Country,
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
